Related Experiment Videos
Endocannabinoids: a new class of vasoactive substances
1School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, UK.
Trends in Pharmacological Sciences
|April 29, 1998
Summary
Endogenous cannabinoids, like anandamide, act as vasorelaxants in the cardiovascular system. Their exact role in blood vessel function, particularly in endothelium-dependent relaxations, remains controversial but is an active area of research.
Area of Science:
- Cardiovascular Pharmacology
- Neuroendocrinology
Background:
- Endogenous cannabinoids (endocannabinoids) are newly identified in the central nervous system (CNS).
- Research is expanding to investigate their cardiovascular effects.
- Anandamide, a prototypic endocannabinoid, exhibits vasorelaxant properties, especially in resistance blood vessels.
Purpose of the Study:
- To explore the cardiovascular actions of endocannabinoids.
- To discuss the proposed role of endocannabinoids in endothelium-dependent relaxations.
- To address the controversy and conflicting findings in the current literature.
Main Methods:
- Literature review and discussion of existing research findings.
- Analysis of studies investigating anandamide's effects on vascular beds.
- Examination of evidence for cannabinoid receptor antagonist sensitivity.
Main Results:
- Anandamide-induced vasorelaxation can be endothelium-independent or -dependent.
- A hypothesis suggests endocannabinoids mediate nitric oxide- and prostanoid-independent endothelium-dependent relaxations.
- Anandamide has been shown to be produced by endothelial cells, despite ongoing controversy.
Conclusions:
- The precise physiological significance of endocannabinoids in the cardiovascular system requires further extensive investigation.
- The role of anandamide in mediating specific components of vascular relaxation is still debated.
- Endocannabinoid signaling represents a complex area with emerging implications for cardiovascular health.